Urabrelimab | m-entrepreneurship.com

Product Name :
Urabrelimab

Search keywords :
Urabrelimab

drugId :
null

Target Vo:
Cluster of differentiation 47

Target Vo Short Name :
CD47

Moa_Name:
Cluster of differentiation 47 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Surface Oncology Inc

Active Company_Name :
Surface Oncology Inc

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bcl2 (YP5001) Mouse mAb Purity & Documentation
PKC alpha Rabbit mAb supplier
CKMT2 Antibody (YA793): CKMT2 Antibody (YA793) is a non-conjugated and Mouse origined monoclonal antibody about 48 kDa, targeting to CKMT2 (3F4). It can be used for WB assays with tag free, in the background of Rat.

Author: Betaine hydrochloride

Related Posts